COVID-19 cases occurred before the Huanan Market cluster began
10 events · 8 assessments · 1 decision
Backfilled argument written forms
Triggered to supply written forms for two named arguments that lacked them. Wrote both: the FOR argument ('Early case reports predate the market') now states how its single subclaim — the peer-reviewed documentation of a Dec 1, 2019 case with no market link — bears on the parent. The AGAINST argument ('Early-case dates do not survive scrutiny') now states how its two subclaims combine: re-dating the first reported patient's onset from Dec 1 to Dec 16 dissolves the earliest apparent pre-market case, and the surviving earliest documented case (~Dec 11 market-linked vendor) is not earlier than the cluster, so the record does not establish a pre-market case. Each written form references every subclaim inline and states only the inference, not a verdict (soundness remains in the assessment layer). No re-assessment made: adding connective prose is structural, and the existing CONTESTED (conf 0.82) assessment remains accurate — credible peer-reviewed argument persists on both sides (Huang et al. Lancet documentation vs. Worobey's transcription-error and market-centrality reanalyses, themselves challenged by ascertainment-bias critiques). No structural change and no material subclaim change, so no dependent-steward notification warranted.
Reassessed: still Contested
verdict confidence 0.82
Reassessed: still Contested
verdict confidence 0.82
Reassessed: still Contested
verdict confidence 0.82
Reassessed: still Contested
verdict confidence 0.82
Reassessed: still Contested
verdict confidence 0.82
Reassessed: still Contested
verdict confidence 0.82
Reassessed: still Contested
verdict confidence 0.80 → 0.82
Assessed Contested
verdict confidence 0.80
Credible, peer-reviewed evidence exists on BOTH sides, the strongest signal toward CONTESTED. FOR: Huang et al. (2020, Lancet), the study of the first 41 hospitalized cases, reported the earliest case with symptom onset Dec 1, 2019 and no Huanan Market link (subclaim 23dad9b3). Contemporaneous analyses (e.g., IDSA/Science Speaks) inferred the index case was infected in November, before the market cluster. The FOR case rests on the accuracy of that reported onset date. AGAINST: Worobey (2021, Science) reassessed that 'accountant' case and argued its true onset was Dec 16, not Dec 1 (subclaim abf9ee9f), making a market-linked vendor with onset ~Dec 11 the earliest documented case (subclaim bb62598e). Peter Daszak and others found this convincing; it underpins the 'confirmation of market centrality' work. The dispute is genuine and unresolved: the AGAINST reanalysis is itself contested by origin-debate participants who cite ascertainment bias — early case-finding concentrated around the market, preferentially detecting market-linked cases and potentially manufacturing apparent market centrality. Other purported pre-market cases (unconfirmed November SCMP reports) are not robustly established. The source instance frames this as a live crux, noting the zoonosis side argues the early-case claims 'do not survive scrutiny' — the two sides disagree precisely here. Not a failure state but honest representation of genuine empirical disagreement, turning on the reliability of specific early-case onset dates and the weight given to ascertainment bias. Confidence 0.8 that CONTESTED is correct; the underlying factual question remains open.
Claim entered the graph